Conversion from Aranesp® to NESP ® in dialysis patients—Exploration of dosing strategies and the feasibility of extending the dosing interval-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Conversion from Aranesp® to NESP ® in dialysis patients—Exploration of dosing strategies and the feasibility of extending the dosing interval

Published:2021-04-20 Issue:9 Volume:26 Page:733-741
ISSN:1320-5358
Container-title:Nephrology
language:en
Short-container-title:Nephrology

Author:

Mok Maggie M. Y.¹,Kwan Lorraine P. Y.¹,Chan Gary C. W.¹,Ma Maggie K. M.¹,Wang Angela Y. M.¹,Yap Desmond Y. H.¹,Choy Cindy B. Y.¹,Tang Sydney C. W.¹^ORCID,Chan Tak Mao¹^ORCID

Affiliation:

1. Division of Nephrology, Department of Medicine Queen Mary Hospital, the University of Hong Kong Hong Kong Hong Kong

Publisher

Wiley

Subject

Nephrology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nep.13882

Reference26 articles.

1. Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)

2. Treatment of renal anemia with recombinant human erythropoietin

3. Use of darbepoetin alfa in the treatment of anaemia of chronic kidney disease: clinical and pharmacoeconomic considerations

4. Pharmacokinetics of Novel Erythropoiesis Stimulating Protein Compared with Epoetin Alfa in Dialysis Patients

5. Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP